Segment disclosures

Company overview

LivaNova PLC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

99 dimension combinations 753 retained observations 29 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · US · Advanced Circulatory Support Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3010562000 USD20231101Open filing evidence
2023-01-01 – 2023-09-3029423000 USD20231101Open filing evidence
2023-01-01 – 2023-03-319664000 USD20230503Open filing evidence
2022-07-01 – 2022-09-308430000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3028183000 USD20231101Open filing evidence
2022-01-01 – 2022-03-3110963000 USD20230503Open filing evidence
2021-01-01 – 2021-12-3153821000 USD20220301Open filing evidence
2020-01-01 – 2020-12-3141094000 USD20220301Open filing evidence
2019-01-01 – 2019-12-3130781000 USD20220301Open filing evidence

Operating Segments · US · Cardiac Surgery

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3049993000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30155530000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · US · Cardiopulmonary Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-3169279000 USD20260506Open filing evidence
2025-01-01 – 2025-12-31275859000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3071946000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30204023000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3071243000 USD20250806Open filing evidence
2025-01-01 – 2025-06-30132077000 USD20250806Open filing evidence
2025-01-01 – 2025-03-3160834000 USD20260506Open filing evidence
2024-01-01 – 2024-12-31242463000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3062504000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30177954000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3064873000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30115450000 USD20250806Open filing evidence
2023-01-01 – 2023-12-31202358000 USD20260225Open filing evidence
2023-07-01 – 2023-09-3048547000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30131372000 USD20231101Open filing evidence
2023-04-01 – 2023-06-3046711000 USD20230726Open filing evidence
2023-01-01 – 2023-06-3082825000 USD20230726Open filing evidence
2022-07-01 – 2022-09-3038476000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30114437000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3037865000 USD20230726Open filing evidence
2022-01-01 – 2022-06-3075961000 USD20230726Open filing evidence
2021-01-01 – 2021-12-31154073000 USD20220301Open filing evidence
2020-01-01 – 2020-12-31132543000 USD20220301Open filing evidence
2019-01-01 – 2019-12-31161471000 USD20220301Open filing evidence

Operating Segments · US · Cardiovascular Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-3052564000 USD20210728Open filing evidence
2021-01-01 – 2021-06-30103600000 USD20210728Open filing evidence
2020-04-01 – 2020-06-3033972000 USD20210728Open filing evidence
2020-01-01 – 2020-06-3084279000 USD20210728Open filing evidence
2020-01-01 – 2020-03-3150307000 USD20200430Open filing evidence
2019-01-01 – 2019-12-31211152000 USD20200302Open filing evidence

Operating Segments · US · Neuromodulation

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3088433000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30245870000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · US · Neuromodulation Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-31115400000 USD20260506Open filing evidence
2025-01-01 – 2025-12-31463602000 USD20260225Open filing evidence
2025-07-01 – 2025-09-30118390000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30343950000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30117226000 USD20250806Open filing evidence
2025-01-01 – 2025-06-30225560000 USD20250806Open filing evidence
2025-01-01 – 2025-03-31108334000 USD20260506Open filing evidence
2024-01-01 – 2024-12-31441022000 USD20260225Open filing evidence
2024-07-01 – 2024-09-30112906000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30330518000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30111683000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30217612000 USD20250806Open filing evidence
2023-01-01 – 2023-12-31407493000 USD20260225Open filing evidence
2023-07-01 – 2023-09-30102475000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30301029000 USD20231101Open filing evidence
2023-01-01 – 2023-03-3194489000 USD20230503Open filing evidence
2022-01-01 – 2022-12-31374542000 USD20240229Open filing evidence
2022-07-01 – 2022-09-3096504000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30275145000 USD20231101Open filing evidence
2022-01-01 – 2022-03-3187210000 USD20230503Open filing evidence
2021-01-01 – 2021-12-31358476000 USD20240229Open filing evidence
2020-01-01 – 2020-12-31282509000 USD20220301Open filing evidence
2020-01-01 – 2020-03-3173276000 USD20200430Open filing evidence
2019-01-01 – 2019-12-31335332000 USD20220301Open filing evidence

Operating Segments · Locations Excluding The United States And Europe · Advanced Circulatory Support Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-3198000 USD20230503Open filing evidence
2022-01-01 – 2022-12-31327000 USD20230227Open filing evidence
2022-04-01 – 2022-06-3059000 USD20220803Open filing evidence
2022-01-01 – 2022-06-30176000 USD20220803Open filing evidence
2022-01-01 – 2022-03-31117000 USD20230503Open filing evidence
2021-01-01 – 2021-12-31518000 USD20230227Open filing evidence
2021-04-01 – 2021-06-30133000 USD20220803Open filing evidence
2021-01-01 – 2021-06-30337000 USD20220803Open filing evidence
2020-01-01 – 2020-12-31200000 USD20230227Open filing evidence
2019-01-01 – 2019-12-31401000 USD20220301Open filing evidence

Operating Segments · Locations Excluding The United States And Europe · Cardiopulmonary Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-3182072000 USD20260506Open filing evidence
2025-01-01 – 2025-12-31308482000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3081220000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30231182000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3078983000 USD20250806Open filing evidence
2025-01-01 – 2025-06-30149962000 USD20250806Open filing evidence
2025-01-01 – 2025-03-3170979000 USD20260506Open filing evidence
2024-01-01 – 2024-12-31273025000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3068841000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30203503000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3070274000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30134662000 USD20250806Open filing evidence
2023-01-01 – 2023-12-31244340000 USD20260225Open filing evidence
2023-07-01 – 2023-09-3061090000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30185488000 USD20231101Open filing evidence
2022-01-01 – 2022-12-31213761000 USD20230227Open filing evidence
2022-07-01 – 2022-09-3053729000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30155437000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3054796000 USD20220803Open filing evidence
2022-01-01 – 2022-06-30101708000 USD20220803Open filing evidence
2021-01-01 – 2021-12-31194344000 USD20230227Open filing evidence
2021-04-01 – 2021-06-3045355000 USD20220803Open filing evidence
2021-01-01 – 2021-06-3087689000 USD20220803Open filing evidence
2020-01-01 – 2020-12-31192127000 USD20230227Open filing evidence
2019-01-01 – 2019-12-31207613000 USD20220301Open filing evidence

Operating Segments · Locations Excluding The United States And Europe · Cardiovascular Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3157629000 USD20200430Open filing evidence

Operating Segments · Locations Excluding The United States And Europe · Neuromodulation Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-3118040000 USD20260506Open filing evidence
2025-01-01 – 2025-12-3164187000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3016614000 USD20251105Open filing evidence
2025-01-01 – 2025-09-3048693000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3016714000 USD20250806Open filing evidence
2025-01-01 – 2025-06-3032079000 USD20250806Open filing evidence
2025-01-01 – 2025-03-3115365000 USD20260506Open filing evidence
2024-01-01 – 2024-12-3158302000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3015033000 USD20251105Open filing evidence
2024-01-01 – 2024-09-3045172000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3015603000 USD20250806Open filing evidence
2024-01-01 – 2024-06-3030139000 USD20250806Open filing evidence
2023-01-01 – 2023-12-3154782000 USD20260225Open filing evidence
2023-01-01 – 2023-03-3112954000 USD20230503Open filing evidence
2022-04-01 – 2022-06-3012654000 USD20220803Open filing evidence
2022-01-01 – 2022-06-3023215000 USD20220803Open filing evidence
2022-01-01 – 2022-03-3110561000 USD20230503Open filing evidence
2021-01-01 – 2021-12-3146261000 USD20220301Open filing evidence
2021-04-01 – 2021-06-3011253000 USD20220803Open filing evidence
2021-01-01 – 2021-06-3020973000 USD20220803Open filing evidence
2020-01-01 – 2020-12-3132916000 USD20220301Open filing evidence
2020-01-01 – 2020-03-315798000 USD20200430Open filing evidence
2019-01-01 – 2019-12-3142953000 USD20220301Open filing evidence

Operating Segments · Rest Of World · Cardiac Surgery

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:RestOfWorldMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3065623000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30196444000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · Rest Of World · Cardiovascular Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:RestOfWorldMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-31268573000 USD20200302Open filing evidence

Operating Segments · Rest Of World · Neuromodulation

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:RestOfWorldMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3013685000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-3031511000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · Rest Of World · Neuromodulation Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:RestOfWorldMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-3142953000 USD20200302Open filing evidence

Operating Segments · Europe · Advanced Circulatory Support Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-3180000 USD20230503Open filing evidence
2022-01-01 – 2022-03-31603000 USD20230503Open filing evidence

Operating Segments · Europe · Cardiac Surgery

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3039810000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30131187000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · Europe · Cardiopulmonary Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-3157304000 USD20260506Open filing evidence
2025-01-01 – 2025-12-31201044000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3050052000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30143605000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3049046000 USD20250806Open filing evidence
2025-01-01 – 2025-06-3093553000 USD20250806Open filing evidence
2025-01-01 – 2025-03-3144507000 USD20260506Open filing evidence
2024-01-01 – 2024-12-31168024000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3040894000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30120387000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3038567000 USD20250806Open filing evidence
2024-01-01 – 2024-06-3079493000 USD20250806Open filing evidence
2023-01-01 – 2023-12-31157414000 USD20260225Open filing evidence

Operating Segments · Europe · Cardiovascular Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-3041434000 USD20210728Open filing evidence
2021-01-01 – 2021-06-3080572000 USD20210728Open filing evidence
2020-04-01 – 2020-06-3028945000 USD20210728Open filing evidence
2020-01-01 – 2020-06-3073078000 USD20210728Open filing evidence
2020-01-01 – 2020-03-3144133000 USD20200430Open filing evidence
2019-01-01 – 2019-12-31176921000 USD20200302Open filing evidence

Operating Segments · Europe · Neuromodulation

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3010425000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-3034080000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · Europe · Neuromodulation Segment

Consolidation Items · Statement Geographical · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-3118348000 USD20260506Open filing evidence
2025-01-01 – 2025-12-3165023000 USD20260225Open filing evidence
2025-07-01 – 2025-09-3014521000 USD20251105Open filing evidence
2025-01-01 – 2025-09-3047445000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3017730000 USD20250806Open filing evidence
2025-01-01 – 2025-06-3032924000 USD20250806Open filing evidence
2025-01-01 – 2025-03-3115194000 USD20260506Open filing evidence
2024-01-01 – 2024-12-3154899000 USD20260225Open filing evidence
2024-07-01 – 2024-09-3011922000 USD20251105Open filing evidence
2024-01-01 – 2024-09-3040919000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3015590000 USD20250806Open filing evidence
2024-01-01 – 2024-06-3028997000 USD20250806Open filing evidence
2023-01-01 – 2023-12-3157435000 USD20260225Open filing evidence
2023-01-01 – 2023-03-3113280000 USD20230503Open filing evidence
2022-01-01 – 2022-03-3112456000 USD20230503Open filing evidence
2020-01-01 – 2020-03-3110583000 USD20200430Open filing evidence
2019-01-01 – 2019-12-3146262000 USD20200302Open filing evidence

Operating Segments · Advanced Circulatory Support Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3140322000 USD20240229Open filing evidence
2023-07-01 – 2023-09-3010952000 USD20231101Open filing evidence
2023-01-01 – 2023-09-3030211000 USD20231101Open filing evidence
2023-01-01 – 2023-03-319842000 USD20230503Open filing evidence
2022-01-01 – 2022-12-3139301000 USD20240229Open filing evidence
2022-07-01 – 2022-09-308636000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3029671000 USD20231101Open filing evidence
2022-04-01 – 2022-06-309352000 USD20220803Open filing evidence
2022-01-01 – 2022-06-3021035000 USD20220803Open filing evidence
2022-01-01 – 2022-03-3111683000 USD20230503Open filing evidence
2021-01-01 – 2021-12-3155459000 USD20240229Open filing evidence
2021-04-01 – 2021-06-3013275000 USD20220803Open filing evidence
2021-01-01 – 2021-06-3026267000 USD20220803Open filing evidence
2021-01-01 – 2021-03-3112992000 USD20220504Open filing evidence
2020-01-01 – 2020-12-3142321000 USD20230227Open filing evidence
2019-01-01 – 2019-12-3131923000 USD20220301Open filing evidence

Operating Segments · Advanced Circulatory Support Segment · US

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3139252000 USD20240229Open filing evidence
2022-01-01 – 2022-12-3137527000 USD20240229Open filing evidence
2021-01-01 – 2021-12-3153821000 USD20240229Open filing evidence

Operating Segments · Advanced Circulatory Support Segment · Locations Excluding The United States And Europe

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30113000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30266000 USD20231101Open filing evidence
2022-07-01 – 2022-09-3092000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30268000 USD20231101Open filing evidence
2022-01-01 – 2022-03-31117000 USD20220504Open filing evidence
2021-01-01 – 2021-03-31204000 USD20220504Open filing evidence

Operating Segments · Advanced Circulatory Support Segment · Europe

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30277000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30522000 USD20231101Open filing evidence
2022-07-01 – 2022-09-30114000 USD20231101Open filing evidence
2022-01-01 – 2022-09-301220000 USD20231101Open filing evidence
2021-01-01 – 2021-12-311120000 USD20220301Open filing evidence
2020-01-01 – 2020-12-311027000 USD20220301Open filing evidence
2019-01-01 – 2019-12-31741000 USD20220301Open filing evidence

Operating Segments · Cardiac Surgery

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-30155426000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30483161000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · Cardiopulmonary Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30221576000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30430231000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31208655000 USD20260506Open filing evidence
2025-01-01 – 2025-12-31785385000 USD20260225Open filing evidence
2025-07-01 – 2025-09-30203218000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30578810000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30199272000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30375592000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31176320000 USD20260506Open filing evidence
2024-01-01 – 2024-12-31683512000 USD20260225Open filing evidence
2024-07-01 – 2024-09-30172239000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30501844000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30173714000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30329605000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31155891000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31604112000 USD20260225Open filing evidence
2023-07-01 – 2023-09-30148955000 RestatedUSD20241031Open filing evidence
2023-01-01 – 2023-09-30438812000 RestatedUSD20241031Open filing evidence
2023-04-01 – 2023-06-30150603000 USD20230726Open filing evidence
2023-01-01 – 2023-06-30282675000 USD20230726Open filing evidence
2022-01-01 – 2022-12-31514198000 RestatedUSD20250225Open filing evidence
2022-07-01 – 2022-09-30120959000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30363854000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30125820000 USD20230726Open filing evidence
2022-01-01 – 2022-06-30242895000 USD20230726Open filing evidence
2021-01-01 – 2021-12-31482979000 USD20230227Open filing evidence
2021-04-01 – 2021-06-30117876000 USD20220803Open filing evidence
2021-01-01 – 2021-06-30226595000 USD20220803Open filing evidence
2020-01-01 – 2020-12-31446732000 USD20230227Open filing evidence
2019-01-01 – 2019-12-31504716000 USD20220301Open filing evidence

Operating Segments · Cardiopulmonary Segment · Europe

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3035190000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30110642000 USD20231101Open filing evidence
2022-07-01 – 2022-09-3028754000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3093980000 USD20231101Open filing evidence
2021-01-01 – 2021-12-31134562000 USD20220301Open filing evidence
2020-01-01 – 2020-12-31122062000 USD20220301Open filing evidence
2019-01-01 – 2019-12-31135632000 USD20220301Open filing evidence

Operating Segments · Cardiovascular Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-30145875000 USD20210728Open filing evidence
2021-01-01 – 2021-06-30289041000 USD20210728Open filing evidence
2020-01-01 – 2020-12-31577083000 USD20210301Open filing evidence
2020-07-01 – 2020-09-30140878000 USD20201029Open filing evidence
2020-01-01 – 2020-09-30417482000 USD20201029Open filing evidence
2020-04-01 – 2020-06-30124535000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30276604000 USD20210728Open filing evidence
2020-01-01 – 2020-03-31152069000 USD20200430Open filing evidence
2019-01-01 – 2019-12-31656646000 USD20210301Open filing evidence
2019-07-01 – 2019-09-30155426000 USD20201029Open filing evidence
2019-01-01 – 2019-09-30483161000 USD20201029Open filing evidence

Operating Segments · Neuromodulation

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-30112543000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30311461000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Operating Segments · Neuromodulation Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30166945000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30318733000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31151788000 USD20260506Open filing evidence
2025-01-01 – 2025-12-31592812000 USD20260225Open filing evidence
2025-07-01 – 2025-09-30149525000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30440088000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30151670000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30290563000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31138893000 USD20260506Open filing evidence
2024-01-01 – 2024-12-31554223000 USD20260225Open filing evidence
2024-07-01 – 2024-09-30139861000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30416609000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30142876000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30276748000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31133872000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31519710000 USD20260225Open filing evidence
2023-07-01 – 2023-09-30128880000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30382784000 USD20241031Open filing evidence
2023-01-01 – 2023-03-31120723000 USD20230503Open filing evidence
2022-01-01 – 2022-12-31476993000 USD20250225Open filing evidence
2022-07-01 – 2022-09-30121835000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30349857000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30117795000 USD20220803Open filing evidence
2022-01-01 – 2022-06-30228022000 USD20220803Open filing evidence
2022-01-01 – 2022-03-31110227000 USD20230503Open filing evidence
2021-01-01 – 2021-12-31456172000 USD20240229Open filing evidence
2021-04-01 – 2021-06-30117636000 USD20220803Open filing evidence
2021-01-01 – 2021-06-30221335000 USD20220803Open filing evidence
2021-01-01 – 2021-03-31103699000 USD20220504Open filing evidence
2020-01-01 – 2020-12-31354444000 USD20220301Open filing evidence
2020-07-01 – 2020-09-3098408000 USD20201029Open filing evidence
2020-01-01 – 2020-09-30245277000 USD20201029Open filing evidence
2020-04-01 – 2020-06-3057212000 USD20200729Open filing evidence
2020-01-01 – 2020-06-30146869000 USD20200729Open filing evidence
2020-01-01 – 2020-03-3189657000 USD20210428Open filing evidence
2019-01-01 – 2019-12-31424547000 USD20220301Open filing evidence
2019-07-01 – 2019-09-30112543000 USD20201029Open filing evidence
2019-01-01 – 2019-09-30311461000 USD20201029Open filing evidence

Operating Segments · Neuromodulation Segment · US

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2020-04-01 – 2020-06-3044215000 USD20200729Open filing evidence
2020-01-01 – 2020-06-30117491000 USD20200729Open filing evidence

Operating Segments · Neuromodulation Segment · Locations Excluding The United States And Europe

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3013744000 USD20231101Open filing evidence
2023-01-01 – 2023-09-3040689000 USD20231101Open filing evidence
2022-07-01 – 2022-09-3014201000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3037416000 USD20231101Open filing evidence
2022-01-01 – 2022-03-3110561000 USD20220504Open filing evidence
2021-01-01 – 2021-03-319720000 USD20220504Open filing evidence
2020-01-01 – 2020-03-315798000 USD20210428Open filing evidence

Operating Segments · Neuromodulation Segment · Europe

Consolidation Items · Statement Business Segments · Statement Geographical

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3012661000 USD20231101Open filing evidence
2023-01-01 – 2023-09-3041066000 USD20231101Open filing evidence
2022-07-01 – 2022-09-3011130000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3037296000 USD20231101Open filing evidence
2021-01-01 – 2021-12-3151435000 USD20220301Open filing evidence
2021-01-01 – 2021-03-3111679000 USD20210428Open filing evidence
2020-01-01 – 2020-12-3139019000 USD20220301Open filing evidence
2020-04-01 – 2020-06-306416000 USD20200729Open filing evidence
2020-01-01 – 2020-06-3016999000 USD20200729Open filing evidence
2020-01-01 – 2020-03-3110583000 USD20210428Open filing evidence
2019-01-01 – 2019-12-3146262000 USD20220301Open filing evidence

Advanced Circulatory Support · US · Cardiac Surgery

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-306313000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-3022290000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Advanced Circulatory Support · US · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3110076000 USD20200430Open filing evidence

Advanced Circulatory Support · Locations Excluding The United States And Europe · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3145000 USD20200430Open filing evidence

Advanced Circulatory Support · Rest Of World · Cardiac Surgery

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;srt:StatementGeographicalAxis=livn:RestOfWorldMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3036000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30310000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Advanced Circulatory Support · Europe · Cardiac Surgery

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-30186000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30497000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Advanced Circulatory Support · Europe · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-31370000 USD20200430Open filing evidence

Advanced Circulatory Support · Cardiac Surgery

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-306535000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-3023097000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Advanced Circulatory Support · Cardiovascular Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:AdvancedCirculatorySupportMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3110491000 USD20200430Open filing evidence

Cardiopulmonary · US · Cardiac Surgery

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3039054000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30119580000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Cardiopulmonary · US · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3136858000 USD20200430Open filing evidence

Cardiopulmonary · Locations Excluding The United States And Europe · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3145275000 USD20200430Open filing evidence

Cardiopulmonary · Rest Of World · Cardiac Surgery

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;srt:StatementGeographicalAxis=livn:RestOfWorldMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3050908000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30152650000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Cardiopulmonary · Europe · Cardiac Surgery

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-3030052000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-3099933000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Cardiopulmonary · Europe · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3134234000 USD20200430Open filing evidence

Cardiopulmonary · Cardiac Surgery

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-30120014000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-30372163000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Cardiopulmonary · Cardiovascular Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:CardiopulmonaryMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-31116367000 USD20200430Open filing evidence

Heart Valves · US · Cardiac Surgery

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:HeartValvesMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiacSurgeryMember
PeriodValueUnitFiledEvidence
2019-07-01 – 2019-09-304626000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence
2019-01-01 – 2019-09-3013660000 USD2019-10-30 · 19:56:27.000ZOpen filing evidence

Heart Valves · US · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:HeartValvesMember;srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-313373000 USD20200430Open filing evidence

Heart Valves · Locations Excluding The United States And Europe · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:HeartValvesMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3112309000 USD20200430Open filing evidence

Heart Valves · Europe · Cardiovascular Segment

Product Or Service · Statement Geographical · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:HeartValvesMember;srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-319529000 USD20200430Open filing evidence

Heart Valves · Cardiovascular Segment

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=livn:HeartValvesMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-3125211000 USD20200430Open filing evidence

US · Operating Segments · Advanced Circulatory Support Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-3137527000 USD20230227Open filing evidence
2022-04-01 – 2022-06-308790000 USD20220803Open filing evidence
2022-01-01 – 2022-06-3019753000 USD20220803Open filing evidence
2022-01-01 – 2022-03-3110963000 USD20220504Open filing evidence
2021-01-01 – 2021-12-3153821000 USD20230227Open filing evidence
2021-04-01 – 2021-06-3012964000 USD20220803Open filing evidence
2021-01-01 – 2021-06-3025524000 USD20220803Open filing evidence
2021-01-01 – 2021-03-3112560000 USD20220504Open filing evidence
2020-01-01 – 2020-12-3141094000 USD20230227Open filing evidence

US · Operating Segments · Cardiopulmonary Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3160834000 USD20250507Open filing evidence
2024-01-01 – 2024-12-31242463000 USD20250225Open filing evidence
2024-07-01 – 2024-09-3062504000 USD20241031Open filing evidence
2024-01-01 – 2024-09-30177954000 USD20241031Open filing evidence
2024-01-01 – 2024-03-3150577000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31202358000 USD20250225Open filing evidence
2023-07-01 – 2023-09-3052281000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30141891000 USD20241031Open filing evidence
2022-01-01 – 2022-12-31171632000 RestatedUSD20250225Open filing evidence
2022-04-01 – 2022-06-3037865000 USD20220803Open filing evidence
2022-01-01 – 2022-06-3075961000 USD20220803Open filing evidence
2021-01-01 – 2021-12-31154073000 USD20230227Open filing evidence
2021-04-01 – 2021-06-3037388000 USD20220803Open filing evidence
2021-01-01 – 2021-06-3073147000 USD20220803Open filing evidence
2020-01-01 – 2020-12-31132543000 USD20230227Open filing evidence

US · Operating Segments · Cardiovascular Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31186125000 USD20210301Open filing evidence
2020-07-01 – 2020-09-3049009000 USD20201029Open filing evidence
2020-01-01 – 2020-09-30133288000 USD20201029Open filing evidence
2019-01-01 – 2019-12-31211152000 USD20210301Open filing evidence

US · Operating Segments · Neuromodulation Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-31108334000 USD20250507Open filing evidence
2024-01-01 – 2024-12-31441022000 USD20250225Open filing evidence
2024-07-01 – 2024-09-30112906000 USD20241031Open filing evidence
2024-01-01 – 2024-09-30330518000 USD20241031Open filing evidence
2024-01-01 – 2024-03-31105929000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31407493000 USD20250225Open filing evidence
2023-07-01 – 2023-09-30102475000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30301029000 USD20241031Open filing evidence
2022-01-01 – 2022-12-31374542000 USD20250225Open filing evidence
2022-04-01 – 2022-06-3091431000 USD20220803Open filing evidence
2022-01-01 – 2022-06-30178641000 USD20220803Open filing evidence
2022-01-01 – 2022-03-3187210000 USD20220504Open filing evidence
2021-04-01 – 2021-06-3091779000 USD20220803Open filing evidence
2021-01-01 – 2021-06-30174079000 USD20220803Open filing evidence
2021-01-01 – 2021-03-3182300000 USD20220504Open filing evidence
2020-01-01 – 2020-12-31282509000 USD20210301Open filing evidence
2020-07-01 – 2020-09-3079854000 USD20201029Open filing evidence
2020-01-01 – 2020-09-30197345000 USD20201029Open filing evidence
2020-01-01 – 2020-03-3173276000 USD20210428Open filing evidence
2019-01-01 – 2019-12-31335332000 USD20210301Open filing evidence

US · Cardiopulmonary Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3072793000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30142072000 USD20260805Open filing evidence
2025-04-01 – 2025-06-3071243000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30132077000 USD20260805Open filing evidence
2024-01-01 – 2024-03-3150577000 USD20240503Open filing evidence
2023-01-01 – 2023-03-3139609000 USD20240503Open filing evidence
2022-07-01 – 2022-09-3038476000 USD20221102Open filing evidence
2022-01-01 – 2022-09-30114437000 USD20221102Open filing evidence
2021-07-01 – 2021-09-3040143000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30113290000 USD20221102Open filing evidence

US · Cardiovascular Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-03-3151036000 USD20210428Open filing evidence
2020-01-01 – 2020-03-3150307000 USD20210428Open filing evidence

US · Neuromodulation Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=country:US;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30126556000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30241956000 USD20260805Open filing evidence
2025-04-01 – 2025-06-30117226000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30225560000 USD20260805Open filing evidence
2024-01-01 – 2024-03-31105929000 USD20240503Open filing evidence
2023-01-01 – 2023-03-3194489000 USD20240503Open filing evidence
2022-01-01 – 2022-12-31374542000 USD20230227Open filing evidence
2021-01-01 – 2021-12-31358476000 USD20230227Open filing evidence
2020-01-01 – 2020-12-31282509000 USD20230227Open filing evidence

Locations Excluding The United States And Europe · Operating Segments · Advanced Circulatory Support Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31319000 USD20240229Open filing evidence
2022-01-01 – 2022-12-31327000 USD20240229Open filing evidence
2021-01-01 – 2021-12-31518000 USD20240229Open filing evidence

Locations Excluding The United States And Europe · Operating Segments · Cardiopulmonary Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3170979000 USD20250507Open filing evidence
2024-01-01 – 2024-12-31273025000 USD20250225Open filing evidence
2024-07-01 – 2024-09-3068841000 USD20241031Open filing evidence
2024-01-01 – 2024-09-30203503000 USD20241031Open filing evidence
2024-01-01 – 2024-03-3164388000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31244340000 USD20250225Open filing evidence
2023-07-01 – 2023-09-3061190000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30185713000 USD20241031Open filing evidence
2023-04-01 – 2023-06-3064723000 USD20230726Open filing evidence
2023-01-01 – 2023-06-30124398000 USD20230726Open filing evidence
2022-01-01 – 2022-12-31214021000 USD20250225Open filing evidence
2022-04-01 – 2022-06-3054796000 USD20230726Open filing evidence
2022-01-01 – 2022-06-30101708000 USD20230726Open filing evidence

Locations Excluding The United States And Europe · Operating Segments · Cardiovascular Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-3051877000 USD20210728Open filing evidence
2021-01-01 – 2021-06-30104869000 USD20210728Open filing evidence
2020-01-01 – 2020-12-31236610000 USD20210301Open filing evidence
2020-07-01 – 2020-09-3053815000 USD20201029Open filing evidence
2020-01-01 – 2020-09-30173062000 USD20201029Open filing evidence
2020-04-01 – 2020-06-3061618000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30119247000 USD20210728Open filing evidence
2019-01-01 – 2019-12-31268573000 USD20210301Open filing evidence

Locations Excluding The United States And Europe · Operating Segments · Neuromodulation Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3115365000 USD20250507Open filing evidence
2024-01-01 – 2024-12-3158302000 USD20250225Open filing evidence
2024-07-01 – 2024-09-3015033000 USD20241031Open filing evidence
2024-01-01 – 2024-09-3045172000 USD20241031Open filing evidence
2024-01-01 – 2024-03-3114536000 USD20250507Open filing evidence
2023-01-01 – 2023-12-3154782000 USD20250225Open filing evidence
2023-07-01 – 2023-09-3013744000 USD20241031Open filing evidence
2023-01-01 – 2023-09-3040689000 USD20241031Open filing evidence
2022-01-01 – 2022-12-3152160000 USD20250225Open filing evidence
2021-01-01 – 2021-12-3146261000 USD20240229Open filing evidence
2020-01-01 – 2020-12-3132916000 USD20210301Open filing evidence
2020-07-01 – 2020-09-308079000 USD20201029Open filing evidence
2020-01-01 – 2020-09-3020458000 USD20201029Open filing evidence
2020-04-01 – 2020-06-306581000 USD20200729Open filing evidence
2020-01-01 – 2020-06-3012379000 USD20200729Open filing evidence
2019-01-01 – 2019-12-3142953000 USD20210301Open filing evidence

Locations Excluding The United States And Europe · Advanced Circulatory Support Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-3092000 USD20221102Open filing evidence
2022-01-01 – 2022-09-30268000 USD20221102Open filing evidence
2021-07-01 – 2021-09-30119000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30456000 USD20221102Open filing evidence

Locations Excluding The United States And Europe · Cardiopulmonary Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3086824000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30168896000 USD20260805Open filing evidence
2025-04-01 – 2025-06-3078983000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30149962000 USD20260805Open filing evidence
2023-01-01 – 2023-12-31244072000 USD20240229Open filing evidence
2022-01-01 – 2022-12-31213761000 USD20240229Open filing evidence
2022-07-01 – 2022-09-3053729000 USD20221102Open filing evidence
2022-01-01 – 2022-09-30155437000 USD20221102Open filing evidence
2021-01-01 – 2021-12-31194344000 USD20240229Open filing evidence
2021-07-01 – 2021-09-3050242000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30137931000 USD20221102Open filing evidence

Locations Excluding The United States And Europe · Neuromodulation Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3020531000 USD20260805Open filing evidence
2026-01-01 – 2026-06-3038571000 USD20260805Open filing evidence
2025-04-01 – 2025-06-3016714000 USD20260805Open filing evidence
2025-01-01 – 2025-06-3032079000 USD20260805Open filing evidence
2024-04-01 – 2024-06-3015603000 USD20240801Open filing evidence
2024-01-01 – 2024-06-3030139000 USD20240801Open filing evidence
2023-04-01 – 2023-06-3013991000 USD20240801Open filing evidence
2023-01-01 – 2023-06-3026945000 USD20240801Open filing evidence
2022-07-01 – 2022-09-3014201000 USD20221102Open filing evidence
2022-01-01 – 2022-09-3037416000 USD20221102Open filing evidence
2021-07-01 – 2021-09-3012047000 USD20221102Open filing evidence
2021-01-01 – 2021-09-3033020000 USD20221102Open filing evidence
2021-04-01 – 2021-06-3011253000 USD20210728Open filing evidence
2021-01-01 – 2021-06-3020973000 USD20210728Open filing evidence
2020-04-01 – 2020-06-306581000 USD20210728Open filing evidence
2020-01-01 – 2020-06-3012379000 USD20210728Open filing evidence

Europe · Operating Segments · Advanced Circulatory Support Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31751000 USD20240229Open filing evidence
2022-01-01 – 2022-12-311447000 USD20240229Open filing evidence
2022-04-01 – 2022-06-30503000 USD20220803Open filing evidence
2022-01-01 – 2022-06-301106000 USD20220803Open filing evidence
2022-01-01 – 2022-03-31603000 USD20220504Open filing evidence
2021-01-01 – 2021-12-311120000 USD20240229Open filing evidence
2021-04-01 – 2021-06-30178000 USD20220803Open filing evidence
2021-01-01 – 2021-06-30406000 USD20220803Open filing evidence
2021-01-01 – 2021-03-31228000 USD20220504Open filing evidence
2020-01-01 – 2020-12-311027000 USD20230227Open filing evidence

Europe · Operating Segments · Cardiopulmonary Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3144507000 USD20250507Open filing evidence
2024-01-01 – 2024-12-31168024000 USD20250225Open filing evidence
2024-07-01 – 2024-09-3040894000 USD20241031Open filing evidence
2024-01-01 – 2024-09-30120387000 USD20241031Open filing evidence
2024-01-01 – 2024-03-3140926000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31157414000 USD20250225Open filing evidence
2023-07-01 – 2023-09-3035484000 USD20241031Open filing evidence
2023-01-01 – 2023-09-30111208000 USD20241031Open filing evidence
2023-04-01 – 2023-06-3039169000 USD20230726Open filing evidence
2023-01-01 – 2023-06-3075452000 USD20230726Open filing evidence
2022-01-01 – 2022-12-31128545000 RestatedUSD20250225Open filing evidence
2022-04-01 – 2022-06-3033159000 USD20230726Open filing evidence
2022-01-01 – 2022-06-3065226000 USD20230726Open filing evidence
2021-01-01 – 2021-12-31134562000 USD20230227Open filing evidence
2021-04-01 – 2021-06-3035133000 USD20220803Open filing evidence
2021-01-01 – 2021-06-3065759000 USD20220803Open filing evidence
2020-01-01 – 2020-12-31122062000 USD20230227Open filing evidence

Europe · Operating Segments · Cardiovascular Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-12-31154348000 USD20210301Open filing evidence
2020-07-01 – 2020-09-3038054000 USD20201029Open filing evidence
2020-01-01 – 2020-09-30111132000 USD20201029Open filing evidence
2019-01-01 – 2019-12-31176921000 USD20210301Open filing evidence

Europe · Operating Segments · Neuromodulation Segment

Statement Geographical · Consolidation Items · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-03-3115194000 USD20250507Open filing evidence
2024-01-01 – 2024-12-3154899000 USD20250225Open filing evidence
2024-07-01 – 2024-09-3011922000 USD20241031Open filing evidence
2024-01-01 – 2024-09-3040919000 USD20241031Open filing evidence
2024-01-01 – 2024-03-3113407000 USD20250507Open filing evidence
2023-01-01 – 2023-12-3157435000 USD20250225Open filing evidence
2023-07-01 – 2023-09-3012661000 USD20241031Open filing evidence
2023-01-01 – 2023-09-3041066000 USD20241031Open filing evidence
2022-01-01 – 2022-12-3150291000 USD20250225Open filing evidence
2022-04-01 – 2022-06-3013710000 USD20220803Open filing evidence
2022-01-01 – 2022-06-3026166000 USD20220803Open filing evidence
2022-01-01 – 2022-03-3112456000 USD20220504Open filing evidence
2021-01-01 – 2021-12-3151435000 USD20240229Open filing evidence
2021-04-01 – 2021-06-3014604000 USD20220803Open filing evidence
2021-01-01 – 2021-06-3026283000 USD20220803Open filing evidence
2021-01-01 – 2021-03-3111679000 USD20220504Open filing evidence
2020-01-01 – 2020-12-3139019000 USD20210301Open filing evidence
2020-07-01 – 2020-09-3010475000 USD20201029Open filing evidence
2020-01-01 – 2020-09-3027474000 USD20201029Open filing evidence
2019-01-01 – 2019-12-3146262000 USD20210301Open filing evidence

Europe · Advanced Circulatory Support Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-30165000 USD20230726Open filing evidence
2023-01-01 – 2023-06-30245000 USD20230726Open filing evidence
2022-04-01 – 2022-06-30503000 USD20230726Open filing evidence
2022-01-01 – 2022-06-301106000 USD20230726Open filing evidence

Europe · Cardiopulmonary Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3061959000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30119263000 USD20260805Open filing evidence
2025-04-01 – 2025-06-3049046000 USD20260805Open filing evidence
2025-01-01 – 2025-06-3093553000 USD20260805Open filing evidence
2024-01-01 – 2024-03-3140926000 USD20240503Open filing evidence
2023-01-01 – 2023-03-3136385000 USD20240503Open filing evidence
2022-07-01 – 2022-09-3028754000 USD20221102Open filing evidence
2022-01-01 – 2022-09-3093980000 USD20221102Open filing evidence
2022-01-01 – 2022-03-3132067000 USD20220504Open filing evidence
2021-07-01 – 2021-09-3032850000 USD20221102Open filing evidence
2021-01-01 – 2021-09-3098609000 USD20221102Open filing evidence
2021-01-01 – 2021-03-3130626000 USD20220504Open filing evidence

Europe · Neuromodulation Segment · Operating Segments

Statement Geographical · Statement Business Segments · Consolidation Items

Source dimensions srt:StatementGeographicalAxis=srt:EuropeMember;us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3019858000 USD20260805Open filing evidence
2026-01-01 – 2026-06-3038206000 USD20260805Open filing evidence
2025-04-01 – 2025-06-3017730000 USD20260805Open filing evidence
2025-01-01 – 2025-06-3032924000 USD20260805Open filing evidence
2024-01-01 – 2024-03-3113407000 USD20240503Open filing evidence
2023-04-01 – 2023-06-3015125000 USD20230726Open filing evidence
2023-01-01 – 2023-06-3028405000 USD20230726Open filing evidence
2023-01-01 – 2023-03-3113280000 USD20240503Open filing evidence
2022-04-01 – 2022-06-3013710000 USD20230726Open filing evidence
2022-01-01 – 2022-06-3026166000 USD20230726Open filing evidence

Advanced Circulatory Support Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-309417000 USD20230726Open filing evidence
2023-01-01 – 2023-06-3019259000 USD20230726Open filing evidence
2022-07-01 – 2022-09-308636000 USD20221102Open filing evidence
2022-01-01 – 2022-09-3029671000 USD20221102Open filing evidence
2022-04-01 – 2022-06-309352000 USD20230726Open filing evidence
2022-01-01 – 2022-06-3021035000 USD20230726Open filing evidence
2021-07-01 – 2021-09-3015399000 USD20221102Open filing evidence
2021-01-01 – 2021-09-3041666000 USD20221102Open filing evidence

Advanced Circulatory Support Segment · Operating Segments · US

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-309197000 USD20230726Open filing evidence
2023-01-01 – 2023-06-3018861000 USD20230726Open filing evidence
2022-04-01 – 2022-06-308790000 USD20230726Open filing evidence
2022-01-01 – 2022-06-3019753000 USD20230726Open filing evidence

Advanced Circulatory Support Segment · US · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-308430000 USD20221102Open filing evidence
2022-01-01 – 2022-09-3028183000 USD20221102Open filing evidence
2021-07-01 – 2021-09-3014925000 USD20221102Open filing evidence
2021-01-01 – 2021-09-3040449000 USD20221102Open filing evidence

Advanced Circulatory Support Segment · Locations Excluding The United States And Europe · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-3055000 USD20230726Open filing evidence
2023-01-01 – 2023-06-30153000 USD20230726Open filing evidence
2022-04-01 – 2022-06-3059000 USD20230726Open filing evidence
2022-01-01 – 2022-06-30176000 USD20230726Open filing evidence

Advanced Circulatory Support Segment · Europe · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:AdvancedCirculatorySupportSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30114000 USD20221102Open filing evidence
2022-01-01 – 2022-09-301220000 USD20221102Open filing evidence
2021-07-01 – 2021-09-30355000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30761000 USD20221102Open filing evidence

Cardiopulmonary Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30225304000 USD20261104Open filing evidence
2026-01-01 – 2026-09-30655535000 USD20261104Open filing evidence
2025-07-01 – 2025-09-30203218000 USD20261104Open filing evidence
2025-01-01 – 2025-09-30578810000 USD20261104Open filing evidence
2024-04-01 – 2024-06-30173714000 USD20240801Open filing evidence
2024-01-01 – 2024-06-30329605000 USD20240801Open filing evidence
2024-01-01 – 2024-03-31155891000 USD20240503Open filing evidence
2023-01-01 – 2023-12-31588977000 USD20240229Open filing evidence
2023-04-01 – 2023-06-30154113000 USD20240801Open filing evidence
2023-01-01 – 2023-06-30289857000 USD20240801Open filing evidence
2023-01-01 – 2023-03-31135744000 RestatedUSD20240503Open filing evidence
2022-01-01 – 2022-12-31500314000 USD20240229Open filing evidence
2022-07-01 – 2022-09-30120959000 USD20221102Open filing evidence
2022-01-01 – 2022-09-30363854000 USD20221102Open filing evidence
2022-01-01 – 2022-03-31117075000 USD20230503Open filing evidence
2021-01-01 – 2021-12-31482979000 USD20240229Open filing evidence
2021-07-01 – 2021-09-30123235000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30349830000 USD20221102Open filing evidence
2021-01-01 – 2021-03-31108719000 USD20220504Open filing evidence

Cardiopulmonary Segment · Operating Segments · US

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31188299000 USD20240229Open filing evidence
2023-01-01 – 2023-03-3136114000 USD20230503Open filing evidence
2022-01-01 – 2022-12-31159489000 USD20240229Open filing evidence
2022-01-01 – 2022-03-3138096000 USD20230503Open filing evidence
2021-01-01 – 2021-12-31154073000 USD20240229Open filing evidence

Cardiopulmonary Segment · Operating Segments · Locations Excluding The United States And Europe

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3164388000 USD20240503Open filing evidence
2023-01-01 – 2023-03-3159750000 RestatedUSD20240503Open filing evidence
2022-01-01 – 2022-03-3146912000 USD20230503Open filing evidence
2021-01-01 – 2021-03-3142334000 USD20220504Open filing evidence

Cardiopulmonary Segment · Operating Segments · Europe

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-3136283000 USD20230503Open filing evidence
2022-01-01 – 2022-03-3132067000 USD20230503Open filing evidence

Cardiopulmonary Segment · US · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3080407000 USD20261104Open filing evidence
2026-01-01 – 2026-09-30222479000 USD20261104Open filing evidence
2025-07-01 – 2025-09-3071946000 USD20261104Open filing evidence
2025-01-01 – 2025-09-30204023000 USD20261104Open filing evidence
2024-04-01 – 2024-06-3064873000 USD20240801Open filing evidence
2024-01-01 – 2024-06-30115450000 USD20240801Open filing evidence
2023-04-01 – 2023-06-3050001000 USD20240801Open filing evidence
2023-01-01 – 2023-06-3089610000 USD20240801Open filing evidence
2022-01-01 – 2022-03-3138096000 USD20220504Open filing evidence
2021-01-01 – 2021-03-3135759000 USD20220504Open filing evidence

Cardiopulmonary Segment · Locations Excluding The United States And Europe · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3087836000 USD20261104Open filing evidence
2026-01-01 – 2026-09-30256732000 USD20261104Open filing evidence
2025-07-01 – 2025-09-3081220000 USD20261104Open filing evidence
2025-01-01 – 2025-09-30231182000 USD20261104Open filing evidence
2024-04-01 – 2024-06-3070274000 USD20240801Open filing evidence
2024-01-01 – 2024-06-30134662000 USD20240801Open filing evidence
2023-04-01 – 2023-06-3064773000 USD20240801Open filing evidence
2023-01-01 – 2023-06-30124523000 USD20240801Open filing evidence

Cardiopulmonary Segment · Europe · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiopulmonarySegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3057061000 USD20261104Open filing evidence
2026-01-01 – 2026-09-30176324000 USD20261104Open filing evidence
2025-07-01 – 2025-09-3050052000 USD20261104Open filing evidence
2025-01-01 – 2025-09-30143605000 USD20261104Open filing evidence
2024-04-01 – 2024-06-3038567000 USD20240801Open filing evidence
2024-01-01 – 2024-06-3079493000 USD20240801Open filing evidence
2023-01-01 – 2023-12-31156606000 USD20240229Open filing evidence
2023-04-01 – 2023-06-3039339000 USD20240801Open filing evidence
2023-01-01 – 2023-06-3075724000 USD20240801Open filing evidence
2022-01-01 – 2022-12-31127064000 USD20240229Open filing evidence
2021-01-01 – 2021-12-31134562000 USD20240229Open filing evidence

Cardiovascular Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-30138634000 USD20211103Open filing evidence
2021-01-01 – 2021-09-30427675000 USD20211103Open filing evidence
2021-01-01 – 2021-03-31143166000 USD20210428Open filing evidence
2020-07-01 – 2020-09-30140878000 USD20211103Open filing evidence
2020-01-01 – 2020-09-30417482000 USD20211103Open filing evidence
2020-01-01 – 2020-03-31152069000 USD20210428Open filing evidence

Cardiovascular Segment · Operating Segments · Locations Excluding The United States And Europe

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-3050361000 USD20211103Open filing evidence
2021-01-01 – 2021-09-30155230000 USD20211103Open filing evidence
2021-01-01 – 2021-03-3152992000 USD20210428Open filing evidence
2020-07-01 – 2020-09-3053815000 USD20211103Open filing evidence
2020-01-01 – 2020-09-30173062000 USD20211103Open filing evidence
2020-01-01 – 2020-03-3157629000 USD20210428Open filing evidence

Cardiovascular Segment · Operating Segments · Europe

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-03-3139138000 USD20210428Open filing evidence
2020-01-01 – 2020-03-3144133000 USD20210428Open filing evidence

Cardiovascular Segment · US · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember;srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-3055068000 USD20211103Open filing evidence
2021-01-01 – 2021-09-30158668000 USD20211103Open filing evidence
2020-07-01 – 2020-09-3049009000 USD20211103Open filing evidence
2020-01-01 – 2020-09-30133288000 USD20211103Open filing evidence

Cardiovascular Segment · Europe · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:CardiovascularSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-3033205000 USD20211103Open filing evidence
2021-01-01 – 2021-09-30113777000 USD20211103Open filing evidence
2020-07-01 – 2020-09-3038054000 USD20211103Open filing evidence
2020-01-01 – 2020-09-30111132000 USD20211103Open filing evidence

Neuromodulation Segment · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30166127000 USD20261104Open filing evidence
2026-01-01 – 2026-09-30484860000 USD20261104Open filing evidence
2025-07-01 – 2025-09-30149525000 USD20261104Open filing evidence
2025-01-01 – 2025-09-30440088000 USD20261104Open filing evidence
2024-04-01 – 2024-06-30142876000 USD20240801Open filing evidence
2024-01-01 – 2024-06-30276748000 USD20240801Open filing evidence
2024-01-01 – 2024-03-31133872000 USD20240503Open filing evidence
2023-04-01 – 2023-06-30133181000 USD20240801Open filing evidence
2023-01-01 – 2023-06-30253904000 USD20240801Open filing evidence
2023-01-01 – 2023-03-31120723000 USD20240503Open filing evidence
2022-01-01 – 2022-12-31476993000 USD20230227Open filing evidence
2022-07-01 – 2022-09-30121835000 USD20221102Open filing evidence
2022-01-01 – 2022-09-30349857000 USD20221102Open filing evidence
2022-04-01 – 2022-06-30117795000 USD20230726Open filing evidence
2022-01-01 – 2022-06-30228022000 USD20230726Open filing evidence
2021-01-01 – 2021-12-31456172000 USD20230227Open filing evidence
2021-07-01 – 2021-09-30113287000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30334622000 USD20221102Open filing evidence
2021-04-01 – 2021-06-30117636000 USD20210728Open filing evidence
2021-01-01 – 2021-06-30221335000 USD20210728Open filing evidence
2020-01-01 – 2020-12-31354444000 USD20230227Open filing evidence
2020-07-01 – 2020-09-3098408000 USD20211103Open filing evidence
2020-01-01 – 2020-09-30245277000 USD20211103Open filing evidence
2020-04-01 – 2020-06-3057212000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30146869000 USD20210728Open filing evidence

Neuromodulation Segment · Operating Segments · US

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=country:US
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-30104065000 USD20230726Open filing evidence
2023-01-01 – 2023-06-30198554000 USD20230726Open filing evidence
2022-04-01 – 2022-06-3091431000 USD20230726Open filing evidence
2022-01-01 – 2022-06-30178641000 USD20230726Open filing evidence
2021-04-01 – 2021-06-3091779000 USD20210728Open filing evidence
2021-01-01 – 2021-06-30174079000 USD20210728Open filing evidence
2020-04-01 – 2020-06-3044215000 USD20210728Open filing evidence
2020-01-01 – 2020-06-30117491000 USD20210728Open filing evidence

Neuromodulation Segment · Operating Segments · Locations Excluding The United States And Europe

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3114536000 USD20240503Open filing evidence
2023-01-01 – 2023-03-3112954000 USD20240503Open filing evidence
2022-01-01 – 2022-12-3152160000 USD20230227Open filing evidence
2021-01-01 – 2021-12-3146261000 USD20230227Open filing evidence
2021-07-01 – 2021-09-3012047000 USD20211103Open filing evidence
2021-01-01 – 2021-09-3033020000 USD20211103Open filing evidence
2020-01-01 – 2020-12-3132916000 USD20230227Open filing evidence
2020-07-01 – 2020-09-308079000 USD20211103Open filing evidence
2020-01-01 – 2020-09-3020458000 USD20211103Open filing evidence

Neuromodulation Segment · Operating Segments · Europe

Statement Business Segments · Consolidation Items · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:StatementGeographicalAxis=srt:EuropeMember
PeriodValueUnitFiledEvidence
2021-04-01 – 2021-06-3014604000 USD20210728Open filing evidence
2021-01-01 – 2021-06-3026283000 USD20210728Open filing evidence
2020-04-01 – 2020-06-306416000 USD20210728Open filing evidence
2020-01-01 – 2020-06-3016999000 USD20210728Open filing evidence

Neuromodulation Segment · US · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:StatementGeographicalAxis=country:US;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30130737000 USD20261104Open filing evidence
2026-01-01 – 2026-09-30372693000 USD20261104Open filing evidence
2025-07-01 – 2025-09-30118390000 USD20261104Open filing evidence
2025-01-01 – 2025-09-30343950000 USD20261104Open filing evidence
2024-04-01 – 2024-06-30111683000 USD20240801Open filing evidence
2024-01-01 – 2024-06-30217612000 USD20240801Open filing evidence
2023-04-01 – 2023-06-30104065000 USD20240801Open filing evidence
2023-01-01 – 2023-06-30198554000 USD20240801Open filing evidence
2022-07-01 – 2022-09-3096504000 USD20221102Open filing evidence
2022-01-01 – 2022-09-30275145000 USD20221102Open filing evidence
2021-07-01 – 2021-09-3088724000 USD20221102Open filing evidence
2021-01-01 – 2021-09-30262803000 USD20221102Open filing evidence
2020-07-01 – 2020-09-3079854000 USD20211103Open filing evidence
2020-01-01 – 2020-09-30197345000 USD20211103Open filing evidence

Neuromodulation Segment · Locations Excluding The United States And Europe · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:StatementGeographicalAxis=livn:LocationsExcludingTheUnitedStatesAndEuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3018782000 USD20261104Open filing evidence
2026-01-01 – 2026-09-3057353000 USD20261104Open filing evidence
2025-07-01 – 2025-09-3016614000 USD20261104Open filing evidence
2025-01-01 – 2025-09-3048693000 USD20261104Open filing evidence
2023-04-01 – 2023-06-3013991000 USD20230726Open filing evidence
2023-01-01 – 2023-06-3026945000 USD20230726Open filing evidence
2022-04-01 – 2022-06-3012654000 USD20230726Open filing evidence
2022-01-01 – 2022-06-3023215000 USD20230726Open filing evidence

Neuromodulation Segment · Europe · Operating Segments

Statement Business Segments · Statement Geographical · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=livn:NeuromodulationSegmentMember;srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3016608000 USD20261104Open filing evidence
2026-01-01 – 2026-09-3054814000 USD20261104Open filing evidence
2025-07-01 – 2025-09-3014521000 USD20261104Open filing evidence
2025-01-01 – 2025-09-3047445000 USD20261104Open filing evidence
2024-04-01 – 2024-06-3015590000 USD20240801Open filing evidence
2024-01-01 – 2024-06-3028997000 USD20240801Open filing evidence
2023-04-01 – 2023-06-3015125000 USD20240801Open filing evidence
2023-01-01 – 2023-06-3028405000 USD20240801Open filing evidence
2022-01-01 – 2022-12-3150291000 USD20230227Open filing evidence
2022-07-01 – 2022-09-3011130000 USD20221102Open filing evidence
2022-01-01 – 2022-09-3037296000 USD20221102Open filing evidence
2021-01-01 – 2021-12-3151435000 USD20230227Open filing evidence
2021-07-01 – 2021-09-3012516000 USD20221102Open filing evidence
2021-01-01 – 2021-09-3038799000 USD20221102Open filing evidence
2020-01-01 – 2020-12-3139019000 USD20230227Open filing evidence
2020-07-01 – 2020-09-3010475000 USD20211103Open filing evidence
2020-01-01 – 2020-09-3027474000 USD20211103Open filing evidence